Literature DB >> 1259395

Influence of cephalosporin antibiotics on blood coagulation and platelet function.

E A Natelson, C H Brown, M W Bradshaw, C P Alfrey, T W Williams.   

Abstract

Administration of cephalothin to normal volunteers in maximal doses of 300 mg/kg per day resulted in a combined defect of platelet function and blood coagulation. No such abnormalities were evident after infusion of cefazolin or cephapirin at a maximal dosage of 200 mg/kg per day. The observed thrombocytopathy was similar to but less severe than that induced by carbenicillin or ticarcillin and was not reflected by a prolonged bleeding time test or impaired prothrombin consumption. Moreover, it was not a consistent finding in those persons receiving cephalothin. A separate defect involving blood coagulation appeared to result from delayed fibrinogen-fibrin polymerization and was evidenced by extended values of the activated partial thromboplastin and thrombin time tests. It remains uncertain whether the abnormalities described may constitute clinically important hemostatic disorders in patients with normal renal function receiving large doses of cephalosporin antibiotics.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259395      PMCID: PMC429481          DOI: 10.1128/AAC.9.1.91

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Study of the effects of ticarcillin on blood coagulation and platelet function.

Authors:  C H Brown; E A Natelson; M W Bradshaw; P Alfrey C; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  The hemostatic defect produced by carbenicillin.

Authors:  C H Brown; E A Natelson; W Bradshaw; T W Williams; C P Alfrey
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

3.  Rapid determination of fibrinogen by thrombokinetics.

Authors:  E A Natelson; D F Dooley
Journal:  Am J Clin Pathol       Date:  1974-06       Impact factor: 2.493

4.  Letter: Coagulopathy with cefazolin in uremia.

Authors:  P I Lerner; A Lubin
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

5.  Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency.

Authors:  W A Craig; P G Welling; T C Jackson; C M Kunin
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Detection of mild factor VIII Deficiency by thrombokinetics.

Authors:  E A Natelson; D Shapiro; D F Smith
Journal:  Am J Clin Pathol       Date:  1975-07       Impact factor: 2.493

7.  Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.

Authors:  J L Bran; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

  7 in total
  7 in total

1.  Cefazolin Induced Liver Injury and Hypoprothrombinemia.

Authors:  Ankur Gupta; Anil K Singh; Khursheed Faridi; Priyanka Jain
Journal:  J Clin Exp Hepatol       Date:  2018-01-05

2.  Alteration of hemostasis associated with cefoperazone treatment.

Authors:  K Andrassy; J Koderisch; S Fritz; H Bechtold; H Sonntag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

3.  In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers.

Authors:  T A Tartaglione; R J Duma; G D Qureshi
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Effect of cefamandole nafate on blood coagulation and platelet function.

Authors:  G M Custer; B R Briggs; R E Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.

Authors:  R L Nichols; M A Wikler; J T McDevitt; A L Lentnek; J A Hosutt
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  Nafcillin-induced platelet dysfunction and bleeding.

Authors:  D P Alexander; M E Russo; D E Fohrman; G Rothstein
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

7.  In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.

Authors:  R Snepar; G Poporad; J Romano; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.